These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15390057)

  • 1. Parkinson's disease home diary: further validation and implications for clinical trials.
    Hauser RA; Deckers F; Lehert P
    Mov Disord; 2004 Dec; 19(12):1409-13. PubMed ID: 15390057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Zesiewicz TA; Sullivan KL; Maldonado JL; Tatum WO; Hauser RA
    Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic motor function diary for patients with Parkinson's disease: a feasibility study.
    Lyons KE; Pahwa R
    Parkinsonism Relat Disord; 2007 Jul; 13(5):304-7. PubMed ID: 16920380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG; Damier P; Hicking C; Laska E; Müller T; Olanow CW; Rascol O; Russ H
    Mov Disord; 2007 Jan; 22(2):179-86. PubMed ID: 17094088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.
    Hauser RA; Russ H; Haeger DA; Bruguiere-Fontenille M; Müller T; Wenning GK
    Clin Neuropharmacol; 2006; 29(6):322-30. PubMed ID: 17095895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments.
    Metman LV; Myre B; Verwey N; Hassin-Baer S; Arzbaecher J; Sierens D; Bakay R
    Mov Disord; 2004 Sep; 19(9):1079-1084. PubMed ID: 15372601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.
    Hauser RA; Friedlander J; Zesiewicz TA; Adler CH; Seeberger LC; O'Brien CF; Molho ES; Factor SA
    Clin Neuropharmacol; 2000; 23(2):75-81. PubMed ID: 10803796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).
    LeWitt PA; Guttman M; Tetrud JW; Tuite PJ; Mori A; Chaikin P; Sussman NM;
    Ann Neurol; 2008 Mar; 63(3):295-302. PubMed ID: 18306243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
    Goetz CG; Leurgans S; Hinson VK; Blasucci LM; Zimmerman J; Fan W; Nguyen T; Hsu A
    Mov Disord; 2008 Jul; 23(10):1479-82. PubMed ID: 18512751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease.
    Nyholm D; Kowalski J; Aquilonius SM
    Mov Disord; 2004 Apr; 19(4):446-51. PubMed ID: 15077243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
    Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
    Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
    Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease.
    Hagell P; Broman JE
    J Sleep Res; 2007 Mar; 16(1):102-9. PubMed ID: 17309769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
    Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Quantitative Motor State Assessment Using a Kinetograph and Patient Diaries in Advanced PD: Data from an Observational Study.
    Ossig C; Gandor F; Fauser M; Bosredon C; Churilov L; Reichmann H; Horne MK; Ebersbach G; Storch A
    PLoS One; 2016; 11(8):e0161559. PubMed ID: 27556806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore.
    Tan LC; Luo N; Nazri M; Li SC; Thumboo J
    Parkinsonism Relat Disord; 2004 Dec; 10(8):493-9. PubMed ID: 15542010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.